XML 35 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
9 Months Ended
Sep. 30, 2017
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2016
 
 
 
 
 
 
 
 
 
 
(In thousands of dollars)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
124,834

 
$
(274,575
)
 
$
366,929

 
$

 
$
217,188

Investing activities:

 

 

 

 

Capital expenditures

 
(9,224
)
 
(3,959
)
 

 
(13,183
)
Acquisition payments, net of cash acquired

 
(50,745
)
 

 

 
(50,745
)
Dividends received from subsidiaries

 
47,621

 

 
(47,621
)
 

Other

 
(257,768
)
 
(335,594
)
 
589,477

 
(3,885
)
Net cash used in investing activities

 
(270,116
)
 
(339,553
)
 
541,856

 
(67,813
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
224,043

 
1,386,397

 
468,890

 
(257,768
)
 
1,821,562

Repayments
(344,804
)
 
(834,688
)
 
(500,879
)
 
(331,709
)
 
(2,012,080
)
Dividends paid by subsidiaries

 

 
(47,621
)
 
47,621

 

Other
(4,073
)
 
(3,494
)
 

 

 
(7,567
)
Net cash (used in) provided by financing activities
(124,834
)
 
548,215

 
(79,610
)
 
(541,856
)
 
(198,085
)
Effect of exchange rate changes on cash and cash equivalents

 

 
1,268

 

 
1,268

Net change in cash and cash equivalents

 
3,524

 
(50,966
)
 

 
(47,442
)
Cash and cash equivalents at the beginning of period

 
38,963

 
121,316

 

 
160,279

Cash and cash equivalents at the end of period
$

 
$
42,487

 
$
70,350

 
$

 
$
112,837

 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended
 
September 30, 2017
 
 
 
 
 
 
 
 
 
 
(In thousands of dollars)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
(28,740
)
 
$
168,603

 
$
(58,752
)
 
$

 
$
81,111

Investing activities:

 

 

 

 

Capital expenditures

 
(7,435
)
 
(8,535
)
 

 
(15,970
)
Dividends received from subsidiaries

 
51,561

 

 
(51,561
)
 

Other

 
(174,032
)
 
16,711

 
160,811

 
3,490

Net cash (used in) provided by investing activities

 
(129,906
)
 
8,176

 
109,250

 
(12,480
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
135,442

 
557,391

 
691,682

 
(173,907
)
 
1,210,608

Repayments

 
(587,485
)
 
(617,301
)
 
13,096

 
(1,191,690
)
Repurchases of common stock
(106,702
)
 

 

 

 
(106,702
)
Dividends paid by subsidiaries

 

 
(51,561
)
 
51,561

 

Other

 
(4,380
)
 

 

 
(4,380
)
Net cash provided by (used in) financing activities
28,740

 
(34,474
)
 
22,820

 
(109,250
)
 
(92,164
)
Effect of exchange rate changes on cash and cash equivalents

 

 
7,485

 

 
7,485

Net change in cash and cash equivalents

 
4,223

 
(20,271
)
 

 
(16,048
)
Cash and cash equivalents at the beginning of period

 
41,552

 
68,579

 

 
110,131

Cash and cash equivalents at the end of period
$

 
$
45,775

 
$
48,308

 
$

 
$
94,083